In recent years, immunotherapies such as CAR T-cells have taken personalised treatment to a new level. These chimeric cells are created after extracting the patient’s T-lymphocytes (specialised cells of the immune system), modifying them, so they recognise specific antigens on the surface of the patient’s cancer cells, and re-injecting them for elimination. However, CAR T-cells...Read More

Opportunità di lavoro per i laureandi e laureati di UniCamillus, con la collaborazione di Randstad Medical. 3 novembre 2022 ore 14.00 - 17.30.Read More